About Matthew Eitner
Form D filings for PD Theranostics from 2022 to 2023 list Matthew Eitner as director.
Form D filings also name Matthew Eitner as a director at Voltron Therapeutics.
Matthew Eitner first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Matthew Eitner in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Matthew Eitner works with at each company, as listed on that company's latest Form D.
PD Theranostics, Inc. · Form D, Dec 14, 2023
PG
Patrick Gallagher
Chief Executive Officer and director
JA
James Ahern
Director
MD
Matthew Duffy
President, Treasurer, Secretary and director
Voltron Therapeutics, Inc. · Form D/A, Nov 9, 2023
PK
Paul Korner
Director
JA
James Ahern
Director
AZ
Anthony Zook
Director
MD
Matthew Duffy
President and director
PG
Patrick Gallagher
Chief Executive Officer and director